Foresight Group (“Foresight”), a FTSE 250 listed private equity and infrastructure investment manager, has completed a €5.3 million investment into DP Medical Systems (“DP Medical” or the “Company”).
DP Medical Systems is a specialist distributor of medical equipment, consumables, and provider of related after-sales services. Founded in 1987 in Chessington, UK, the Company has expanded its reach through a network of six sites across the UK. It opened its Dublin office in 2019 and has since scaled its team and customer base in Ireland, which now represents a material part of the Company’s performance.
DP Medical primarily supports customers in ear, nose and throat, gynaecology and dental settings. It is committed to promoting positive patient outcomes by supplying its customers with the most innovative medical technologies available. It is committed to transitioning to a sustainability-focused operating model with a clear plan to materially reduce its emissions profile and waste over the coming years.
Since 2019, DP Medical has achieved significant growth, supported by the material and growing contribution made by its Irish operations. Foresight’s investment will enable its ambitious management team to drive growth through the continued expansion of its operations in Ireland, increasing its team across the UK, introducing new innovative products to market, and delivering market-leading after-sales support to its customers. Foresight will also support DP Medical’s plans to reduce its carbon emissions and improve its sustainability practices.
PMSI provided CDD to support the transaction, covering key investment themes such as: growth drivers of the medical capital equipment market; dynamics of the after-sales servicing market; the long-term trend toward outpatient and community care, as well as DP Medical’s competitive positioning within the UK and Irish markets.
Article
PMSI supports NorthEdge's investment into Antib...
NorthEdge have completed a multi-million-pound investment into Antibody Analytics (AA), a contract research organisation (CRO) and trusted provider of i...